GENKAI HUANG: Open Payments
NPI 1053949362 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,286 in 118 payments from 21 companies in 2025. Trend: 2023 $217 · 2024 $2,083 · 2025 $3,286
Food & beverage: $3,286
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $734 |
| Novo Nordisk Inc | 11 | $433 |
| Phathom Pharmaceuticals, Inc. | 8 | $374 |
| ABBVIE INC. | 15 | $352 |
| GlaxoSmithKline, LLC. | 25 | $271 |
| Abbott Laboratories | 5 | $180 |
| Axsome Therapeutics, Inc. | 4 | $170 |
| Kowa Pharmaceuticals America, Inc. | 12 | $140 |
| Dexcom, Inc. | 1 | $115 |
| PFIZER INC. | 5 | $94 |
Products named: VOQUEZNA, AIRSUPRA, BREZTRI, TRELEGY ELLIPTA, QULIPTA, FREESTYLE LIBRE 3, Ozempic, Auvelity.
Industry payments across TX — which companies pay providers there.
